{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:19:54Z","timestamp":1786699194271,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"am","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.urology.2022.05.034","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T11:09:28Z","timestamp":1654945768000},"page":"158-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Gu\u00e9rin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1362-4344","authenticated-orcid":false,"given":"Takamitsu","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makito","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soki","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Numakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohide","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikiya","family":"Taoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaka","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Habuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2022.05.034_bib0001","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2022.05.034_bib0002","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.juro.2007.11.079","article-title":"Late age (85 years or older) peak incidence of bladder cancer","volume":"179","author":"Schultzel","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.05.034_bib0003","series-title":"Urotherial Tumors of the Bladder","first-page":"2409","article-title":"Campbell-Walsh urology","author":"Messing","year":"2007"},{"key":"10.1016\/j.urology.2022.05.034_bib0004","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.urolonc.2009.07.020","article-title":"Bladder cancer in the elderly","volume":"27","author":"Shariat","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2022.05.034_bib0005","unstructured":"EAU guidelines: non-muscle-invasive bladder cancer. Available at:https:\/\/uroweb.org\/guideline\/non-muscle-invasive-bladder-cancer\/. Accessed November 4, 2021."},{"key":"10.1016\/j.urology.2022.05.034_bib0006","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.urolonc.2016.11.014","article-title":"Characterizing intermediate-risk non-muscle-invasive bladder cancer: implications for the definition of intermediate risk and treatment strategy","volume":"35","author":"Matsumoto","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2022.05.034_bib0007","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2013a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2022.05.034_bib0008","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10522-017-9682-z","article-title":"Immunosenescence and cancer","volume":"18","author":"Pawelec","year":"2017","journal-title":"Biogerontology"},{"key":"10.1016\/j.urology.2022.05.034_bib0009","doi-asserted-by":"crossref","first-page":"e16223","DOI":"10.1097\/MD.0000000000016223","article-title":"The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer","volume":"98","author":"Cal\u00f2","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.urology.2022.05.034_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/CU9.0000000000000011","article-title":"Efficacy and toxicity of intravesical Bacillus Calmette-Gu\u00e9rin therapy in olderly patients with non-muscle-invasive bladder cancer","volume":"15","author":"Matsuoka","year":"2021","journal-title":"Curr Urol"},{"key":"10.1016\/j.urology.2022.05.034_bib0011","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jjco\/hyq241","article-title":"Could patient age influence tumor recurrence rate in non-muscle-invasive bladder cancer patients treated with BCG immunotherapy?","volume":"41","author":"Yuge","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urology.2022.05.034_bib0012","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1007\/s00345-020-03130-1","article-title":"Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer","volume":"38","author":"Krajewski","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2022.05.034_bib0013","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","article-title":"The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy","volume":"175","author":"Joudi","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.05.034_bib0014","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2007.03.024","article-title":"Age and outcome of superficial bladder cancer treated with bacille Calmette-Gu\u00e9rin therapy","volume":"70","author":"Herr","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.05.034_bib0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bju.13474","volume":"118","author":"Oddens","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2022.05.034_bib0016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.urolonc.2007.04.005","article-title":"Effect of advanced age on the development of complications from intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"26","author":"Heiner","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2022.05.034_bib0017","first-page":"155","article-title":"Analysis of tumor suppressor gene-induced senescence","volume":"223","author":"Campisi","year":"2003","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.urology.2022.05.034_bib0018","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrc2393","article-title":"Telomere dysfunction and tumour suppression: the senescence connection","volume":"8","author":"Deng","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urology.2022.05.034_bib0019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2013a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2022.05.034_bib0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.2009.05370.x","article-title":"Potential role of immunosenescence in cancer development","volume":"1197","author":"Fulop","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.urology.2022.05.034_bib0021","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00262-021-02870-2","article-title":"The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells","volume":"70","author":"Shiga","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.urology.2022.05.034_bib0022","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ctrv.2016.02.006","article-title":"Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: a systematic review and meta-analysis","volume":"45","author":"Nishijima","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.urology.2022.05.034_bib0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jgo.2017.02.001","article-title":"Immunotherapy comes of age: immune aging & checkpoint inhibitors","volume":"8","author":"Elias","year":"2017","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.urology.2022.05.034_bib0024","article-title":"Immune checkpoints inhibitors in the management of high-risk non-muscle-invasive bladder cancer. A scoping review","volume":"26","author":"Garc\u00eda-Perdomo","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2022.05.034_bib0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-06-1210","article-title":"Cumulative incidence in competing risks data and competing risks regression analysis","volume":"13","author":"Kim","year":"2007","journal-title":"Clin Cancer Res"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522004551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522004551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:48:55Z","timestamp":1758768535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429522004551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"alternative-id":["S0090429522004551"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2022.05.034","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Gu\u00e9rin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2022.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}